Blog / Archives
Hot Fun in the Summertime: NYC Hits 92 degrees;Healthcare Plan Draft Out
Update after close 7/13: Health Care draft bill appears to have stabilized biotech despite opposition. ETFs end in green but XLV is flat. More analysis is coming tomorrow. ========= It's Vacation...
2017 Life Science Review #1: Big Biotech Gains for First Half
Big Biotech Gains for Stocks in First Half Rayno Life Science Picks Top Winners YTD: Foundation Medicine (FMI) up 124.6%, bluebird bio (BLUE) up 70.26%, XBI up 20.9%. Large cap winners since...
Sector Rotation or Another Tech Wreck?
Tech Wreck Part 2? Or Just Profit Taking. Sector Rotation Away from Large Cap Growth (QQQ) to Value (XLF) Volatility Returns Tech and biotech stocks were hit from sector rotation with the NASDAQ...
BIO International Convention 2017 Update #3: Genomics and Future of Personalized Medicine
Genomics and the Future of Personalized Medicine and Diagnostics Description of Track The opening plenary of the Personalized Medicine & Diagnostics Track will feature J. Craig Venter, Founder,...
BIO International Convention 2017 Updates #2-BIG Data Drives Precision Medicine
Big Data Provides Pathway to Precision Medicine Description of Track Speaker Atul Butte, MD,Ph.D. Director, UCSF Institute for Computational Health Sciences The remarkable ascent of Big Data for...
BIO 2017 International #1: CAR-T Therapies on Solid Tumors
CAR-T Therapies on Solid Tumors Here is an excellent summary by BIOtechNow Editors on the application of CAR-T (Chimeric Antigen Receptor) T-Cell therapies on solid tumors. Up until now CAR-T shows...
BIOtech Breakout: Healthcare Stocks Lead the Way…Update-1
6/27/17 Red Screen Day: Sell-Off in Biotechs Possibly Due to Senate Delay in Healthcare Vote IBB down 1.54% at $314.80. Momentum stocks are weak; NASDAQ down 1.2%. Take profits on XBI trade at $78...
Good Day Today: XBI Breaks Through to YTD Highs…Update
Market Update 12n 6/20: Biotechs Continue to Rally IBB up 1.87% to $305.50; XBI up 1.93% to $75.60 As we have covered biotech ETFs in the past the XBI is one of our core positions for aggressive...
Rayno Life Science Portfolio 2017
Update-1 6/27/17 With the XBI up 34% YTD at $79.34, take a little off for future trades. ===== Rayno Life Science Portfolio 2017 YTD 6/15 Top winners YTD: BLUE up 78.9%,FMI up 121.5%,RHHBY up 13%,...
Biotech Avoids Tech Wreck of June 9…Update-2 June 15
June 15-Update 2 after close...Biotechs Down with Techs-Red Screen Day Very few winners today: IBB down 0.77%, XBI down 1.36% to $71.55 near 52 week high of $73. ABBV near new highs at $70.60, BLUE...